Please login to the form below

Not currently logged in

pharma pricing

This page shows the latest pharma pricing news and features for those working in and with pharma, biotech and healthcare.

Novo bolstered by new diabetes, obesity products

Novo bolstered by new diabetes, obesity products

Insulin prices have been a hotly-debated topic as pharma companies face pricing pressure from patient groups and government officials, particularly in the US. ... In September, the Danish drug-maker said it will launch a cut-price version of its insulin

Latest news

More from news
Approximately 2 fully matching, plus 105 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 20 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 14 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs


Add my company

Viseven is a full cycle digital agency with 10 years expertise in developing content for the global pharmaceutical market delivering...

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....